Literature DB >> 9219685

Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove.

Z Zeng1, A R Castaño, B W Segelke, E A Stura, P A Peterson, I A Wilson.   

Abstract

CD1 represents a third lineage of antigen-presenting molecules that are distantly related to major histocompatibility complex (MHC) molecules in the immune system. The crystal structure of mouse CD1d1, corresponding to human CD1d, at 2.8 resolution shows that CD1 adopts an MHC fold that is more closely related to that of MHC class I than to that of MHC class II. The binding groove, although significantly narrower, is substantially larger because of increased depth and it has only two major pockets that are almost completely hydrophobic. The extreme hydrophobicity and shape of the binding site are consistent with observations that human CD1b and CD1c can present mycobacterial cell wall antigens, such as mycolic acid and lipoarabinomannans. However, mouse CD1d1 can present very hydrophobic peptides, but must do so in a very different way from MHC class Ia and class II molecules.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9219685     DOI: 10.1126/science.277.5324.339

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  180 in total

1.  Ligand-independent assembly of recombinant human CD1 by using oxidative refolding chromatography.

Authors:  M M Altamirano; A Woolfson; A Donda; A Shamshiev; L Briseño-Roa; N W Foster; D B Veprintsev; G De Libero; A R Fersht; C Milstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

Review 2.  Antigen recognition by human gamma delta T cells: pattern recognition by the adaptive immune system.

Authors:  C T Morita; R A Mariuzza; M B Brenner
Journal:  Springer Semin Immunopathol       Date:  2000

Review 3.  The multiple roles of major histocompatibility complex class-I-like molecules in mucosal immune function.

Authors:  R S Blumberg; Y van de Wal; S Claypool; N Corazza; B Dickinson; E Nieuwenhuis; R Pitman; G Spiekermann; X Zhu; S Colgan; W I Lencer
Journal:  Acta Odontol Scand       Date:  2001-06       Impact factor: 2.331

Review 4.  Immune recognition, response, and regulation: how T lymphocytes do it.

Authors:  S Joyce
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 5.  A new aspect in glycolipid biology: glycosphingolipids as antigens recognized by T lymphocytes.

Authors:  G De Libero; A Donda; H J Gober; V Manolova; Z Mazorra; A Shamshiev; L Mori
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

6.  Crystal structure of soluble MD-1 and its interaction with lipid IVa.

Authors:  Sung-il Yoon; Minsun Hong; Gye Won Han; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

Review 7.  Innate self recognition by an invariant, rearranged T-cell receptor and its immune consequences.

Authors:  Aleksandar K Stanic; Jang-June Park; Sebastian Joyce
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

8.  CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion.

Authors:  Silke Gillessen; Yuri N Naumov; Edward E S Nieuwenhuis; Mark A Exley; Frederick S Lee; Nicolas Mach; Andrew D Luster; Richard S Blumberg; Masaru Taniguchi; Steven P Balk; Jack L Strominger; Glenn Dranoff; S Brian Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-07       Impact factor: 11.205

9.  Polymorphisms in CD1d affect antigen presentation and the activation of CD1d-restricted T cells.

Authors:  Michael I Zimmer; Hanh P Nguyen; Bin Wang; Honglin Xu; Angela Colmone; Kyrie Felio; Hak-Jong Choi; Ping Zhou; Maria-Luisa Alegre; Chyung-Ru Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

Review 10.  Lipid and small-molecule display by CD1 and MR1.

Authors:  Ildiko Van Rhijn; Dale I Godfrey; Jamie Rossjohn; D Branch Moody
Journal:  Nat Rev Immunol       Date:  2015-09-21       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.